Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Accounts Payable

$1.54M

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX Accounts Payable

Latest reported$1.54Mperiod endingJun 30, 2026

Latest reported$1.54Mperiod endingJun 30, 2026

LCTX Quarterly Accounts Payable ($200.00K → $1.54M)

Quarterly accounts payable

High-resolution chart · PNG

LCTX accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Accounts Payable — Quarterly (USD)
Period ending	Accounts Payable (USD)
Jun 30, 2001	330,561
Mar 31, 2001	136,433
Dec 31, 2000	359,749
Sep 30, 2000	113,915
Jun 30, 2000	308,170
Mar 31, 2000	127,355
Dec 31, 1999	595,512
Sep 30, 1999	500,000
Jun 30, 1999	300,000
Mar 31, 1999	300,000
Sep 30, 1998	100,000
Jun 30, 1998	200,000
Mar 31, 1998	300,000
Dec 31, 1997	300,000
Sep 30, 1997	200,000
Jun 30, 1997	200,000
Mar 31, 1997	100,000
Dec 31, 1996	200,000
Sep 30, 1996	200,000
Jun 30, 1996	100,000
Sep 30, 1995	100,000
Jun 30, 1995	300,000
Mar 31, 1995	100,000
Dec 31, 1994	300,000
Sep 30, 1994	100,000
Jun 30, 1994	0
Mar 31, 1994	100,000
Dec 31, 1993	100,000
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	100,000
Sep 30, 1992	100,000
Jun 30, 1992	200,000
Mar 31, 1992	200,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.